Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Equity Ratio: 2013-2025

Historic Equity Ratio for Amphastar Pharmaceuticals (AMPH) over the last 12 years, with Sep 2025 value amounting to 0.47.

  • Amphastar Pharmaceuticals' Equity Ratio fell 1.01% to 0.47 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.47, marking a year-over-year decrease of 1.01%. This contributed to the annual value of 0.46 for FY2024, which is 9.84% up from last year.
  • As of Q3 2025, Amphastar Pharmaceuticals' Equity Ratio stood at 0.47, which was down 0.59% from 0.47 recorded in Q2 2025.
  • In the past 5 years, Amphastar Pharmaceuticals' Equity Ratio ranged from a high of 0.71 in Q4 2022 and a low of 0.39 during Q3 2023.
  • Moreover, its 3-year median value for Equity Ratio was 0.46 (2024), whereas its average is 0.47.
  • As far as peak fluctuations go, Amphastar Pharmaceuticals' Equity Ratio slumped by 44.57% in 2023, and later climbed by 22.23% in 2024.
  • Amphastar Pharmaceuticals' Equity Ratio (Quarterly) stood at 0.66 in 2021, then grew by 7.39% to 0.71 in 2022, then plummeted by 40.68% to 0.42 in 2023, then rose by 9.84% to 0.46 in 2024, then declined by 1.01% to 0.47 in 2025.
  • Its Equity Ratio stands at 0.47 for Q3 2025, versus 0.47 for Q2 2025 and 0.46 for Q1 2025.